- Meeting abstract
- Open Access
Waist-to-height ratio as a predictor of metabolic syndrome in a population with different degrees of glucose tolerance
- Tássia Cividanes Pazinato1Email author,
- Bárbara Limberger Nedel,
- Anize Delfino von Frankenberg1,
- Vanessa Piccoli1,
- Luciana Pavan Antoniolli1,
- Mayara Abichequer Beer1,
- Letícia Maria Tedesco Silva1,
- Rodrigo Soares de Souza Marques1,
- Leonardo de Andrade Mesquita1,
- Monique de Moura Machado1,
- André Fernandes Reis1 and
- Fernando Gerchman1
© Pazinato et al. 2015
- Published: 11 November 2015
- Metabolic Syndrome
- Waist Circumference
- Adiponectin Level
- Ambulatory Blood Pressure
- Normal Glucose Tolerance
Intra-abdominal fat (IAF) accumulation is related to metabolic syndrome (MS), type 2 diabetes mellitus (DM2) and cardiovascular disease (CVD). Among the indices that reflect IAF, waist-to-height ratio (WtHR) has been proposed as an index that can not only estimate IAF, but adjust it to body size, which possibly makes it an useful tool for risk prediction of MS and CVD.
To compare the WtHR with other indices of central obesity and body fat distribution to identify MS.
We designed a cross-sectional study of consecutive individuals from 2 university hospitals of different Brazilian sites. Subjects (n=655, women 52.1%, 57.4±11.6 yrs.; mean±SD) were submitted to an evaluation that consisted of anthropometric assessment (BMI, WtHR, Waist-to-hip ratio and electric bioimpedanciometry), 2h 75g OGTT (estimation of insulin sensitivity index of Stumvoll [ISI]), lipids, A1c, fasting glucose, C-reactive protein (US-CRP), fibrinogen, adiponectin and ambulatory blood pressure measurement. MS was defined (MS 82.8%) according to the harmonization criteria performed by different medical societies. Patients were categorized by glucose tolerance status in normal glucose tolerance (NGT 24.1%), prediabetes (PDM 37.5%) and diabetes (DM 33.5%). A two-sided P value <0.05 was considered significant.
WtHR increased progressively with decreasing glucose tolerance status (NGT 0.59 vs. PDM 0.60 vs. DM 0.63; P<0.001) and with the presence of MS compared to the absence of MS (0.62 vs. 0.55; P<0.001). WtHR was positively related to US-CRP levels (r=0.521; P<0.001), total body fat (r=0.599; P<0.001), Stumvoll ISI (r=0.427; P<0.001), fibrinogen (r=0.275; P<0.001), triglycerides (r=0.239; P<0.001) and fasting glucose (r=0.109; P=0.006) and was inversely related to adiponectin levels (r=-0.143; P<0.001). ROC curve analyses showed that WtHR was superior to BMI (AUC 0.743 vs. 0.677; P<0.001), but similar to waist circumference (AUC 0.743 vs. 0.756; P=0.341) in predicting MS. The performance of WtHR was still greater than that of BMI after excluding waist circumference from MS criteria (AUC 0.639 vs. 0.576; P=0.005).
WtHR was superior to BMI and similar to waist circumference in defining MS, suggesting that it may be used as a tool to discriminate subjects at greater risk of developing diabetes and cardiovascular disease.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.